Thanks to the largest fundraising year in University history, Wake Will: The Campaign for Wake Forest has raised more than $402 million of the $600 million Reynolda Campus goal, making it possible for students like Sarah Millsaps (’16) to say “yes” to Wake Forest.
From improving the lives of people suffering from debilitating diseases to turning waves in the Reynolds gym pool into electricity, Wake Forest researchers raised the bar of scientific excellence yet again during the 2013-2014 academic year.
Wake Forest Chemist Amanda Jones is the recipient of the National Science Foundation’s prestigious Career Award. Jones will use the $390,000 in award funding to study powerful and environmentally friendly gold catalysts for use in the pharmaceutical industry.
The key to developing drought-resistant tomatoes may be hidden in the genes of their ancestors. Rising junior Kathleen DiNapoli is on a hunt to find it.
Charles Iacovou will become the next Dean of the Wake Forest University School of Business, effective July 1.
A new compound created by Wake Forest chemists could help scientists probe the secrets behind deadly forms of cancer, Alzheimer’s and heart disease. The research is featured in the current edition of the Journal of the American Chemical Society.
Blue-footed boobies are on the decline in the Galápagos. A new study shows a low-sardine diet could be the reason behind the 50 percent drop in population.
An iPhone app developed by a team of Wake Forest freshmen could one day enable patrons at campus restaurants to vote for what songs play over the speakers.
Lighthouse Reef Atoll is one of the most pristine marine environments in the Caribbean Sea due to its remote location. Students taking an Ecology and Conservation of Coral Reefs class spent their spring break exploring the Atoll’s startling array of biodiversity.
Move over, pink. The fight against breast cancer now wears Old Gold and Black as a team of graduate students from Wake Forest Schools of Business, Law and Medicine work together to take a promising, but underfunded, cancer therapy to market.